Global Contraceptive Drugs Market Size study & Forecast, by Product ( Oral, Injectable , Patches), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels & NGOs and Others) and Regional Analysis, 2022-2029
Global Contraceptive Drugs Market is valued approximately USD 16.59 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2029. Contraceptive Drugs are consumed by female for birth control. The Contraceptive Drugs market is expanding because of factors such as increasing prevalence of unwanted pregnancies and increasing prevalence of sexually transmitted diseases (STDs). However, rising prevalence of infertility and adverse effects associated with the use of contraceptive drugs and devices may halt market growth.
Throughout the forecast period, the market growth is anticipated to be driven by the rising incidence of Sexually Transmitted Diseases (STDs) and the rising number of women with unmet need for contraceptive medications & devices. Almost 1.1 billion women worldwide in 2019 who are reproductive age (15 to 49 years) need family planning, according to the World Health Organization. Over 842 million of them use contraceptive techniques for family planning, and 270 million of them have unmet contraception needs. Furthermore, The Department of Economic and Social Affairs, Population Division of the United Nations reports that in 2019 that there are 1.9 billion women in the world who are reproductive age (15–49). Around 80 million people utilize conventional methods, while about 842 million women use contemporary contraception, including oral medications and injectables. In addition, growing awareness regarding contraceptive drugs leads to product demand creating a lucrative growth to the market. Along with these, wide availability of reimbursement policies in developed countries is expected to fuel the market adoption rate in the forecasted period.
The key regions considered for the Global Contraceptive Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Piramal Enterprises Ltd.
Organon group of companies
Johnson & Johnson Services, Inc.
AbbVie Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Amneal Pharmaceuticals, Inc.
Bayer AG
Agile Therapeutics.
Recent Developments in the Market:
In February 2020, The U.S. FDA has authorized Agile Therapeutics to commercialize Twirla (levonorgestrel and ethinyl estradiol), a transdermal patch for women.
In January 2020, Bayer AG and Darй Bioscience, Inc. have signed a licence agreement to distribute Ovaprene after the U.S. Food and Drug Administration gives the experimental contraception medicine market clearance.
Global Contraceptive Drugs Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Oral
Injectable
Patches
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Clinics
Online Channels
Public Channels & NGOs
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Throughout the forecast period, the market growth is anticipated to be driven by the rising incidence of Sexually Transmitted Diseases (STDs) and the rising number of women with unmet need for contraceptive medications & devices. Almost 1.1 billion women worldwide in 2019 who are reproductive age (15 to 49 years) need family planning, according to the World Health Organization. Over 842 million of them use contraceptive techniques for family planning, and 270 million of them have unmet contraception needs. Furthermore, The Department of Economic and Social Affairs, Population Division of the United Nations reports that in 2019 that there are 1.9 billion women in the world who are reproductive age (15–49). Around 80 million people utilize conventional methods, while about 842 million women use contemporary contraception, including oral medications and injectables. In addition, growing awareness regarding contraceptive drugs leads to product demand creating a lucrative growth to the market. Along with these, wide availability of reimbursement policies in developed countries is expected to fuel the market adoption rate in the forecasted period.
The key regions considered for the Global Contraceptive Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Piramal Enterprises Ltd.
Organon group of companies
Johnson & Johnson Services, Inc.
AbbVie Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Amneal Pharmaceuticals, Inc.
Bayer AG
Agile Therapeutics.
Recent Developments in the Market:
In February 2020, The U.S. FDA has authorized Agile Therapeutics to commercialize Twirla (levonorgestrel and ethinyl estradiol), a transdermal patch for women.
In January 2020, Bayer AG and Darй Bioscience, Inc. have signed a licence agreement to distribute Ovaprene after the U.S. Food and Drug Administration gives the experimental contraception medicine market clearance.
Global Contraceptive Drugs Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Oral
Injectable
Patches
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Clinics
Online Channels
Public Channels & NGOs
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Contraceptive Drugs Market, by Region, 2019-2029 (USD Billion)
1.2.2. Contraceptive Drugs Market, by Product, 2019-2029 (USD Billion)
1.2.3. Contraceptive Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL CONTRACEPTIVE DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL CONTRACEPTIVE DRUGS MARKET DYNAMICS
3.1. Contraceptive Drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Government and NGO initiatives to promote contraceptive methods
3.1.1.2. Increasing prevalence of unwanted pregnancies
3.1.2. Market Challenges
3.1.2.1. Rising prevalence of infertility
3.1.2.2. Adverse effects associated with the use of contraceptive drugs and devices
3.1.3. Market Opportunities
3.1.3.1. Increasing prevalence of sexually transmitted diseases (STDs)
CHAPTER 4. GLOBAL CONTRACEPTIVE DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL CONTRACEPTIVE DRUGS MARKET, BY PRODUCT
6.1. Market Snapshot
6.2. Global Contraceptive Drugs Market by Product, Performance - Potential Analysis
6.3. Global Contraceptive Drugs Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Contraceptive Drugs Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Injectable
6.4.3. Patches
CHAPTER 7. GLOBAL CONTRACEPTIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL
7.1. Market Snapshot
7.2. Global Contraceptive Drugs Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Contraceptive Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Contraceptive Drugs Market, Sub Segment Analysis
7.4.1. Hospital Pharmacy
7.4.2. Retail Pharmacy
7.4.3. Clinics
7.4.4. Online Channels
7.4.5. Public Channels & NGOs
7.4.6. Others
CHAPTER 8. GLOBAL CONTRACEPTIVE DRUGS MARKET, REGIONAL ANALYSIS
8.1. Contraceptive Drugs Market, Regional Market Snapshot
8.2. North America Contraceptive Drugs Market
8.2.1. U.S. Contraceptive Drugs Market
8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Contraceptive Drugs Market
8.3. Europe Contraceptive Drugs Market Snapshot
8.3.1. U.K. Contraceptive Drugs Market
8.3.2. Germany Contraceptive Drugs Market
8.3.3. France Contraceptive Drugs Market
8.3.4. Spain Contraceptive Drugs Market
8.3.5. Italy Contraceptive Drugs Market
8.3.6. Rest of Europe Contraceptive Drugs Market
8.4. Asia-Pacific Contraceptive Drugs Market Snapshot
8.4.1. China Contraceptive Drugs Market
8.4.2. India Contraceptive Drugs Market
8.4.3. Japan Contraceptive Drugs Market
8.4.4. Australia Contraceptive Drugs Market
8.4.5. South Korea Contraceptive Drugs Market
8.4.6. Rest of Asia Pacific Contraceptive Drugs Market
8.5. Latin America Contraceptive Drugs Market Snapshot
8.5.1. Brazil Contraceptive Drugs Market
8.5.2. Mexico Contraceptive Drugs Market
8.5.3. Rest of Latin America Contraceptive Drugs Market
8.6. Rest of The World Contraceptive Drugs Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Piramal Enterprises Ltd.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Organon group of companies
9.2.3. Johnson & Johnson Services, Inc.
9.2.4. AbbVie Inc.
9.2.5. Pfizer Inc.
9.2.6. Teva Pharmaceutical Industries Ltd.
9.2.7. Viatris Inc.
9.2.8. Amneal Pharmaceuticals, Inc.
9.2.9. Bayer AG
9.2.10. Agile Therapeutics
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Contraceptive Drugs Market, by Region, 2019-2029 (USD Billion)
1.2.2. Contraceptive Drugs Market, by Product, 2019-2029 (USD Billion)
1.2.3. Contraceptive Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL CONTRACEPTIVE DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL CONTRACEPTIVE DRUGS MARKET DYNAMICS
3.1. Contraceptive Drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Government and NGO initiatives to promote contraceptive methods
3.1.1.2. Increasing prevalence of unwanted pregnancies
3.1.2. Market Challenges
3.1.2.1. Rising prevalence of infertility
3.1.2.2. Adverse effects associated with the use of contraceptive drugs and devices
3.1.3. Market Opportunities
3.1.3.1. Increasing prevalence of sexually transmitted diseases (STDs)
CHAPTER 4. GLOBAL CONTRACEPTIVE DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL CONTRACEPTIVE DRUGS MARKET, BY PRODUCT
6.1. Market Snapshot
6.2. Global Contraceptive Drugs Market by Product, Performance - Potential Analysis
6.3. Global Contraceptive Drugs Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Contraceptive Drugs Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Injectable
6.4.3. Patches
CHAPTER 7. GLOBAL CONTRACEPTIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL
7.1. Market Snapshot
7.2. Global Contraceptive Drugs Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Contraceptive Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Contraceptive Drugs Market, Sub Segment Analysis
7.4.1. Hospital Pharmacy
7.4.2. Retail Pharmacy
7.4.3. Clinics
7.4.4. Online Channels
7.4.5. Public Channels & NGOs
7.4.6. Others
CHAPTER 8. GLOBAL CONTRACEPTIVE DRUGS MARKET, REGIONAL ANALYSIS
8.1. Contraceptive Drugs Market, Regional Market Snapshot
8.2. North America Contraceptive Drugs Market
8.2.1. U.S. Contraceptive Drugs Market
8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Contraceptive Drugs Market
8.3. Europe Contraceptive Drugs Market Snapshot
8.3.1. U.K. Contraceptive Drugs Market
8.3.2. Germany Contraceptive Drugs Market
8.3.3. France Contraceptive Drugs Market
8.3.4. Spain Contraceptive Drugs Market
8.3.5. Italy Contraceptive Drugs Market
8.3.6. Rest of Europe Contraceptive Drugs Market
8.4. Asia-Pacific Contraceptive Drugs Market Snapshot
8.4.1. China Contraceptive Drugs Market
8.4.2. India Contraceptive Drugs Market
8.4.3. Japan Contraceptive Drugs Market
8.4.4. Australia Contraceptive Drugs Market
8.4.5. South Korea Contraceptive Drugs Market
8.4.6. Rest of Asia Pacific Contraceptive Drugs Market
8.5. Latin America Contraceptive Drugs Market Snapshot
8.5.1. Brazil Contraceptive Drugs Market
8.5.2. Mexico Contraceptive Drugs Market
8.5.3. Rest of Latin America Contraceptive Drugs Market
8.6. Rest of The World Contraceptive Drugs Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Piramal Enterprises Ltd.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Organon group of companies
9.2.3. Johnson & Johnson Services, Inc.
9.2.4. AbbVie Inc.
9.2.5. Pfizer Inc.
9.2.6. Teva Pharmaceutical Industries Ltd.
9.2.7. Viatris Inc.
9.2.8. Amneal Pharmaceuticals, Inc.
9.2.9. Bayer AG
9.2.10. Agile Therapeutics
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Contraceptive Drugs Market, report scope
TABLE 2. Global Contraceptive Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Contraceptive Drugs Market estimates & forecasts by Product 2019-2029 (USD Billion)
TABLE 4. Global Contraceptive Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 5. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Contraceptive Drugs Market
TABLE 70. List of primary sources, used in the study of global Contraceptive Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Contraceptive Drugs Market, report scope
TABLE 2. Global Contraceptive Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Contraceptive Drugs Market estimates & forecasts by Product 2019-2029 (USD Billion)
TABLE 4. Global Contraceptive Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 5. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Contraceptive Drugs Market
TABLE 70. List of primary sources, used in the study of global Contraceptive Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Contraceptive Drugs Market, research methodology
FIG 2. Global Contraceptive Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Contraceptive Drugs Market, key trends 2021
FIG 5. Global Contraceptive Drugs Market, growth prospects 2022-2029
FIG 6. Global Contraceptive Drugs Market, porters 5 force model
FIG 7. Global Contraceptive Drugs Market, pest analysis
FIG 8. Global Contraceptive Drugs Market, value chain analysis
FIG 9. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Contraceptive Drugs Market, regional snapshot 2019 & 2029
FIG 15. North America Contraceptive Drugs Market 2019 & 2029 (USD Billion)
FIG 16. Europe Contraceptive Drugs Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Contraceptive Drugs Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Contraceptive Drugs Market 2019 & 2029 (USD Billion)
FIG 19. Global Contraceptive Drugs Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Contraceptive Drugs Market, research methodology
FIG 2. Global Contraceptive Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Contraceptive Drugs Market, key trends 2021
FIG 5. Global Contraceptive Drugs Market, growth prospects 2022-2029
FIG 6. Global Contraceptive Drugs Market, porters 5 force model
FIG 7. Global Contraceptive Drugs Market, pest analysis
FIG 8. Global Contraceptive Drugs Market, value chain analysis
FIG 9. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Contraceptive Drugs Market, regional snapshot 2019 & 2029
FIG 15. North America Contraceptive Drugs Market 2019 & 2029 (USD Billion)
FIG 16. Europe Contraceptive Drugs Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Contraceptive Drugs Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Contraceptive Drugs Market 2019 & 2029 (USD Billion)
FIG 19. Global Contraceptive Drugs Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
